Rapid eye movement sleep behavior disorder ( RBD) is a kind of sleep disorder in which a person experiences some physical movements and unpleasant dreams…
View More Disrupted connectivity in Parkinson’s disease (PD) with the probable Rapid eye movement behavior disorder ( RBD)Tag: parkinson's disease
Parkinson Disease Mortality Increased in the US From 1999 to 2019
HealthDay News — From 1999 to 2019, mortality from Parkinson’s disease (PD) increased in the United States, according to a study published online Oct. 27 in Neurology.…
View More Parkinson Disease Mortality Increased in the US From 1999 to 2019Deterioration of Brain Cells in Parkinson’s Disease Is Slowed by Blocking the Bach1 Protein
Bach1, a protein that blocks the expression of genes associated with neuroprotection, has been implicated in Parkison’s disease. Researchers say blocking Bach1 slows the deterioration…
View More Deterioration of Brain Cells in Parkinson’s Disease Is Slowed by Blocking the Bach1 ProteinStudy Identifies New Genes Tied to Higher Risk for Parkinson Disease
Several susceptibility genes for Parkinson disease (PD) were identified using a transcriptome-wide association study (TWAS), and a phenome-wide association study for each single nucleotide polymorphism…
View More Study Identifies New Genes Tied to Higher Risk for Parkinson DiseaseCaregivers Report Aggression in Patients With Advanced PD and Related Disorders
Caregivers reported physical and sexual aggression among patients living with advanced Parkinson disease and related disorders (PDRD), according to a summary of caregiver reports published…
View More Caregivers Report Aggression in Patients With Advanced PD and Related DisordersSafety of Solriamfetol for Excessive Daytime Sleepiness in Parkinson’s Disease
A new study revealed there is no adverse events or safety concerns were identified in participants with PD treated with solriamfetol. Excessive daytime sleepiness (EDS),…
View More Safety of Solriamfetol for Excessive Daytime Sleepiness in Parkinson’s DiseaseBlarcamesine Increases SIGMAR1 Expression, Shows Improvements in Parkinson Disease Dementia
Patients who received high-dose blarcamesine experienced a 14.51-point MDS-UPDRS total score improvement compared to placebo in a phase 2 study of the Anavex Life Sciences…
View More Blarcamesine Increases SIGMAR1 Expression, Shows Improvements in Parkinson Disease DementiaDancing and Parkinson’s Disease during the pandemic
According to new research, dancing at home is accessible and usable for people with Parkinson’s Disease (PD). Parkinson’s disease (PD) is one of the most…
View More Dancing and Parkinson’s Disease during the pandemicSport climbing in Parkinson’s disease
A new investigation revealed that sport climbing is highly effective and feasible in mildly to moderately affected Parkinson’s disease (PD) patients Besides pharmacological and invasive therapies,…
View More Sport climbing in Parkinson’s disease